Olpruva
Active Ingredient(s): Sodium PhenylbutyrateFDA Approved: * December 22, 2022
Pharm Company: * ACER
Category: Hyperammonemia
Sodium phenylbutyrate is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid.[2] The compound is used to treat urea cycle disorders, because its metabolites offer an alternative pathway to the urea cycle to allow excretion of excess nitrogen.[3][4] It is an orphan drug, marketed by Ucyclyd Pharma under the trade name Buphenyl, by Swedish Orphan International (Sweden) as Ammonaps, aby Fyrlklövern Scandinavia as... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
